FDA.reportPublic FDA data

Blenrep

Product NDC
0173-0896
Requested package NDC
0173-0896-01
11-digit product format
001730896
Labeler code
0173
Product ID
0173-0896_15fcefaf-72a9-438a-aaa5-39e2227375b1
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Belantamab
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
GlaxoSmithKline LLC
Application
BLA761158
Marketing category
BLA
Marketing start
2020-08-05
Marketing end
0000-00-00
Substance
BELANTAMAB MAFODOTIN
Active strength
50 mg/mL
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0173-08960173-0896-01DDiscontinued by firm2026-07-31

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0173-0896-01EA - Each0173-0896b020d89d-71f8-42f5-9619-e3563359b26512020-09-14

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761158Blenrepbelantamab mafodotin-blmf351(a)Disc2026-06-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0173-0896-01001730896011 VIAL in 1 CARTON (0173-0896-01) > 2 mL in 1 VIAL1 vial2020-08-050000-00-00NoNoCurrent